Screening tool does not cut distress in cancer patients

September 7, 2013
Screening tool does not cut distress in cancer patients
Distress monitoring and needs assessment using the Distress Thermometer and Problem List does not appear to be cost-effective in improving mood states in cancer patients, according to research published online Sept. 3 in the Journal of Clinical Oncology.

(HealthDay)—Distress monitoring and needs assessment using the Distress Thermometer and Problem List (DT&PL) does not appear to be cost-effective in improving mood states in cancer patients, according to research published online Sept. 3 in the Journal of Clinical Oncology.

William Hollingworth, Ph.D., of the University of Bristol in the United Kingdom, and colleagues randomly assigned 220 patients starting radiotherapy or chemotherapy to an intervention group (112 patients) or a control group (108 patients). The effect of a 25-minute intervention with the DT&PL on patient outcomes and health care costs was assessed.

The researchers found that, among the patients receiving the intervention, one-third reported high levels of distress; most patients reported physical (84 percent) or emotional (56 percent) problems. No evidence of an effect of the DT&PL was observed for psychological distress, quality of life, or health care costs. Fewer than 3 percent of patients in either group were referred to a clinical psychologist.

"Needs can be identified using short, simple, and inexpensive screening tools," writes the author of an accompanying editorial. "However, results need to be followed-up with further assessment of specific needs and appropriate referral and treatment."

Explore further: Dexamethasone beats placebo for cancer-related fatigue

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Dexamethasone beats placebo for cancer-related fatigue

August 1, 2013
(HealthDay)—For patients with advanced cancer, dexamethasone is better than placebo for reducing cancer-related fatigue (CRF), according to a study published online July 29 in the Journal of Clinical Oncology.

Barrier assessment improves care for elderly with diabetes

March 19, 2013
(HealthDay)—For older adults with diabetes, an active intervention involving assessment of barriers to self-care and development of strategies to cope with these barriers is superior to usual care, according to research ...

ASCO: Cancer patients want to talk about costs with docs

May 31, 2013
(HealthDay)—Although financial distress is common, even in insured patients, discussion of costs of cancer care with doctors rarely happens, according to research to be presented at the annual meeting of the American Society ...

Study finds most adult survivors of childhood cancer cope well, but some are susceptible to symptoms of depression

September 4, 2013
The majority of adult survivors of childhood cancer reported no or few symptoms of psychological distress over a 13 year follow-up period according to a study published in the British Journal of Cancer, today (Wednesday).

Intervention assists end-of-life decisions in advanced cancer

August 5, 2013
(HealthDay)—In advanced cancer patients, an intervention with a pamphlet and discussion to assist with end-of-life decision making is associated with earlier placement of do-not-resuscitate (DNR) orders and less likelihood ...

Mindfulness-based cognitive therapy beneficial in diabetes

December 11, 2012
(HealthDay)—For patients with diabetes and low levels of emotional well-being, mindfulness-based cognitive therapy (MBCT) improves emotional distress and health-related quality of life, according to a study published online ...

Recommended for you

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.